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ABSTRACT 
Galectins (Gal) are a family of glycan-binding proteins characterized by their affinity for β–
galactosides. Galectin-1 (Gal-1), a dimeric lectin with two galactoside-binding sites, regulates 
cancer progression and immune responses. Coordination chemistry has been engaged to 
develop versatile multivalent neoglycoconjugates for binding Gal-1. In this study we  report  a 
fast and original method to synthesize hybrid gold nanoparticles in which a hydrochloride-
lactose-modified chitosan, named CTL is mixed with  dicarboxylic acid-terminated 
polyethylene-glycol (PEG), leading to shell-like hybrid polymer-sugar-metal nanoparticles 
(CTL-PEG-AuNPs). The aim of this paper, is to preliminary study the interaction of the CTL-
PEG-AuNPs with a target protein, namely Gal-1, under specific conditions. The molecular 
interaction has been measured by Transmission Electron Microscopy (TEM), UV-Vis and 
Raman Spectroscopy on a large range of Gal-1 concentrations (from 0 to 10
-8 
M). We 
observed that the interaction was strongly dependent on the Gal-1 concentration at the surface 
of the gold nanoparticles. 
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Introduction 
Gold nanoparticles (AuNPs) are used in various fields as medical nanovectors, transducers or 
nanosensors
1
. The research on new synthesis methods is still an active field in order to 
optimize the AuNPs properties for such applications
2,3,4
. In a  previous study we have 
investigated a fast synthesis method to realize polymer-modified AuNPs using dycarboxylic 
PEG, collagen or bisphosphonate (BPO) as stabilizers in order to demonstrate high stability 
and efficacy under realistic biomedical conditions
5,6,7,8
. Other authors have synthetized hybrid 
metal nanoparticles based on chitosan and chitosan-derivatives as sugar stabilizers for various 
applications in the field of the nanomedicine
9,10,11,12,13
. 
Lactose-modified chitosan, shortly termed CTL (in other papers termed Chitlac), is a 
branched polysaccharide synthetized via reductive N-alkylation of primary amines by lactose 
moieties (Figure S1 in Supporting Information)
14
. CTL is a ternary heteropolysaccharide 
composed of β-1→4 linked glucosamine (D unit), N-acetyl-glucosamine (A unit) and N-lactit-
1-yl glucosamine (L unit) sugars. The presence of lactose residues grafted on the chitosan 
backbone ensures some advantages with respect to the original polymer, such as a higher 
solubility at neutral pH than most of commercial chitosans, a miscibility with polyanions to 
form soluble complexes without associative phase separation, and the possibility to form gels 
upon mixing with boric acid as cross-linker under physiological conditions of pH and 
osmolarity
15
. From the biological point of view, it has been proven that CTL fosters  the 
aggregation of an osteoblast-like cell line in vitro, stimulates the cell proliferation and 
enhances the alkaline phosphatase activity
16
. Contextually, the aggregation of chondrocytes 
and the stimulation of collagen and glycosaminoglycans production was also 
demonstrated
17,18
. It was found that the bioactivity of CTL is ascribed to the specific 
interaction between the lactitol groups of the polymer and the β-galactoside-binding protein 
Galectin-1
19,20
. 
Galectin-1 (Gal-1) is a protein differentially expressed in various normal and pathologic 
tissues and displays a wide range of activities in biological processes. Increased Gal-1 
expression has been reported in different tumors such as colon, breast, lung, head and neck, 
ovarian, prostate carcinomas and Hodgkin lymphoma
21,22,23,24,25,26,27
. The expression of this 
protein in various cancer cells appears to affect tumor progression steps, mainly angiogenesis, 
apoptosis, cell migration and metastatic spread. It has been recently demonstrated that Gal-1 
overexpression positively correlates to tumor aggressiveness, poor patients’ survival and 
prognosis
28
. Several studies identify this lectin as a promising therapeutic and prognostic 
marker in cancer
29
. Topologically, Gal-1 represents a particularly interesting challenge for 
targeting with synthetic, multivalent ligands
30
 since it is a rigid dimer
31
 with two binding sites 
oriented in opposite directions. The positions of the binding sites compete with each other at 
linear distance up to 6 nm. Since the main biological targets of Gal-1 reside on the cell 
surface, one strategy for targeting Gal-1 is to use structures that mimic the fluidity and 
adaptability of cellular membranes. Detecting and identifying this protein in biological media 
can be then of primary importance. However, its specific recognition needs the interaction 
with a bioreceptor providing a high affinity with Gal-1. The bioreceptor must be grafted at the 
surface of sensing transducer that could induce a modification of its affinity with the analyte 
to be detected. Most of methods used to detect biomolecules require strict molecular 
recognition events
32
. In these latter cases, grafted biomolecules at the AuNP surface can act as 
bioreceptors having a high affinity for the targeted analytes
33
. The analyte target detection 
depends on the affinity constant of the bioreceptor to the targeted analyte
34
. The goal of the 
present paper is to preliminary investigate the possibility to exploit the interaction between 
CTL and Gal-1 for the development of a nanocarrier system based on CTL-decorated AuNPs 
for the detection and the tracking of the lectin protein. 
We would like to understand if the grafting will modify the interaction and thus if some 
parameters can be optimized in order to improve this interaction in terms of sensing purpose. 
The specific binding affinity between CTL and Gal-1 was as certained and quantified by 
means of Surface Plasmon Resonance. Shell-like hybrid CTL-PEG-gold nanoparticles (CTL-
PEG-AuNPs) were synthesized and characterized. The interaction between Gal-1 and CTL-
PEG-AuNPs was then investigated using Localised Surface Plasmon (LSP), Transmission 
Electron Microscopy (TEM) and Raman spectroscopy as analytical tools.  
 
RESULTS AND DISCUSSION 
CTL-Galectin 1 binding affinity 
In a previous paper
1
, we evidenced experimentally for the existence of the interaction between 
the polymer CTL and the lectin Gal-1 able to induce specific biological responses.  
Herein, the Surface Plasmon Resonance (SPR) technique was exploited to demonstrate in 
vitro the presence of a molecular interaction between Gal-1 and CTL and the equilibrium 
binding constants were calculated. To this aim CTL was immobilized on the chip via 
amidation chemistry. SPR signals were recorded using different concentrations of Gal-1 and 
corrected for the contribution of the solvent as shown in Figure S3 in Supporting Information. 
SPR analysis performed on non-derived polysaccharide (chitosan) allows clearly of deducing 
that the specific interaction exists only in the case of CTL (data not shown). Interestingly, for 
CTL the SPR signal for concentrations of Gal-1 equal to or greater than 1 μM does not seem 
to reach a constant value, indicative of the achievement of a steady state. On the contrary, in 
the time interval in which the plateau would be expected, the signal increases linearly with 
slopes increasing with Gal-1 concentrations. 
The analysis of the kinetic data (see Supporting Information) were carried out by 
adopting a model unimolecular (1:1) for the protein-substrate system providing the values of 
the kinetic association constant (ka = 6 x 10
3
 M
-1
s
-1
) and kinetic dissociation constant (kd = 6 x 
10
-2
 M
-1
s
-1
) of the complex. The calculated affinity constant, defined as KA = ka / kd, was 1 x 
10
5
 M
-1
. The affinity constant was also calculated independently using the steady state values 
of the temporal trace at the different protein concentrations. The value of KA obtained from 
the kinetic data was comparable with those obtained from the responses to equilibrium: 1 x 
10
5
 M
-1 
in the first case and 4 x 10
5
 M
-1
 in the second one. 
Gal-1 binds relatively strongly to CTL, in fact the calculated affinity constant (1 x 10
5
 M
-1
) is 
stronger than that reported in literature by Miller et al. for the binding of Gal-1 with the 
disaccharide lactose (Gal-β(1→4)-Glc)36. The multivalent structure of CTL may contribute to 
this high analogy for Gal-1, something that is viewed  with many cell-surface glycoconjugates 
that bear multiple galectin-binding sites
37
 
38
.  Moreover this value is in the same range of 
values reported for the affinity constants for binding to both linear and complex branched 
glycans bearing terminal β(1→4)-linked galactose side chains39.   
 
Formation mechanism of CTL-PEG AuNPs  
In the last years Spadavecchia et al. have extensively investigated the synthesis of hybrid 
nanoparticles and the effect of various surfactant agents on the growth process
5-6
. Recently 
Furlani-Sacco et al. have developed colloidal coacervates using the bioactive chitosan-
derivative CTL by ionotropic gelation
11
. Contextually, other authors have designed a 
nanocomposite hydrogel based on natural polysaccharides, CTL and gold nanoparticles with 
considerable antimicrobial activity
20
. 
 
 Scheme 1. Representation of the synthesis of CTL-PEG-AuNPs (Please note that drawings are not in 
scale and are not intended to be representative of the full samples composition). 
 
After demonstrating the existence of a high binding affinity between CTL and Gal-1, the 
objective of this paper was to evaluate the interaction between Gal-1 and CTL under 
formation of stable complexes of PEGylated Au (III)-CTL as active excipients of gold 
nanoparticles. The major discrepancy with other chemical procedures, is that PEG and CTL b 
participate to the stabilization of AuNPs via complexation between their ketone and amino 
groups with chloride auric ions. In our case, the formation of gold NPs from AuCl4
-
 
comprehends the subsequent steps (scheme 1): 
(1) Complexation of PEG with AuCl4
-
 and initial reduction of the polymer-metal complex 
to generate gold cluster
7
. 
PEG-COOH
Stacking
Gold Salt 
CTL-PEG-AuNPs
NaBH4
Chitlac
Stacking
Au
: AuCl4
-
: PEG-COOH
: Chitlac
: Chit-AuCl2
-
(2) Stacking process of CTL by electrostatic adsorption onto the PEGylayed gold clusters. 
(3) Final reduction of metal ions at the vicinity of the clusters, growth of AuNPs and 
colloidal stabilization through the dicarboxylic PEG and CTL polymers. 
In the first step, PEG dicarboxylic acid (PEG) is added into HAuCl4 aqueous solution, to 
complex with it as previously described 
6-7
. In the second step, the positively amino charged (-
NH3
+
 and -NRH2
+
) groups  of CTL in water solution,  favor  strong electrostatic interactions 
with the negatively charged complex PEG-AuCl4
-
, the latter playing  a strategic role in the 
growth process of AuNPs
6
. The addiction of CTL in the PEG-AuCl4
- 
solution increases the 
kinetics of reduction by a further complexation with the Au ions
6
. Such effect controls the 
simultaneous chemical and steric arrangement of CTL and PEG between AuCl4
-
 on the 
surface of gold seeds during the growth process of nanoparticles. In the third step, the 
reduction by NaBH4 induces the grow process of hybrid nanoparticles. 
All products were entirely characterized by UV-Vis absorption spectroscopy, TEM and 
Raman spectroscopy. The UV-visible spectrum of CTL-PEG-AuNPs was characterized by a 
surface plasmon band at 530 nm and a peak at 234 nm assigned to the CTL-PEG absorption 
(Figure 1-A; Figure S4 in Supporting Information), which confirms the formation of AuNPs. 
In addition, the bright violet-blue color of the resulting nanoparticles and the UV-Vis spectra 
remained unaltered after six months at room temperature validating the realization of stable 
colloidal solution. 
Representative TEM images of the colloidal solutions are shown in Figure 2 panel B. CTL-
PEG-AuNPs exhibit a thin distribution in size and shape, with an average size of 20 ± 0.5 nm 
as estimated from 450 particles on a given TEM image. Anyway, some of the particles 
showed a somewhat faceted shape as a result of their nano-crystalline nature. Spadavecchia et 
al. have studied the synthesis of analogous nanomaterials using dicarboxylic PEG
5-6, 8, 35,40
  
obtaining PEG-AuNPs with a smaller size, i.e.  about 6.7 ± 0.5 nm
8
. On the basis of previous 
studies 
8, 35, 40
 we assumed that, when CTL was added to the complex with the PEG-AuCl4
-
, 
the chemical and steric arrangement between PEG and CTL influences the final size of the 
nanoparticles. 
The Raman spectra of free CTL and CTL-PEG-AuNPs in water exhibit many bands in 
the region 500-2000 cm
-1 
(Figure 1-C). The wide band observed around 1600 cm
-1
 on the 
CTL-PEG-AuNPs of raman spectra, is assigned to the water. One of the raman fingerprint of 
the CTL-PEG-AuNPs is the presence of a band around 263 cm
-1
 and a double peak at 446-485 
cm
-1 
disappeared. These bands can be assigned to the gold chloride stretches, ν (Au-Cl), and δ 
(OAuO) in aliphatic chains, and is a clear evidence of the formation of a complex between 
AuCl2
-
 and PEG and CTL in solution. The common peak at 430 cm
-1
 is due to the vibrations δ 
(OH…O), ν (OH…O) of the PEG. Based on the spectrochemical and previously theoretical 
results, we assumed that Au
3+
 ions promoted the deprotonation of the PEG
35
 . The spectra of 
PEG molecules free as control was previously described in literature
35
 
8
 (Figure S1-A in 
Supporting information).Only few bands remain as the two bands around 1000 cm
-1
 and the 
one around 1620 cm
-1
. The other ones are less intense or completely disappeared. For 
instance, the strong band at 1375 cm
-1
 assigned to C=O carbonyl stretching of CTL disappears 
after formation of gold nanoparticles. A double peak at 1065-111 cm
-1
 due to C-O-C 
stretching in backbone of CTL disappears after PEG stacking onto gold nanoparticles. 
Furthermore, new bands also appear as an intense triplet at 1211-1243-1289 cm
-1
 due to C-O 
plane deformation of carboxylic acid and a strong peak at 1471 cm
-1
 assigned to ν C-C 
stretching. These bands are due to the  variation of the steric conformation of the polymers 
and become more prominent upon complexation, as described previously
35,40
. 
 
 
 Figure 1. (A) Normalized UV-Vis absorption spectrum of CTL-PEG-AuNPs, (B) TEM images of 
CTL-PEG-AuNPs, and size distribution histogram (B’). (C) Raman spectrum of CTL-PEG-AuNPs 
(red line) compared to free CTL spectrum as control (black line). (A-B) Scale bars: 100 nm. (C) 
Raman spectra. Experimental conditions: λexc = 785 nm; laser power 20 mW; accumulation time 180 s. 
 
Galectin Active Interaction 
Galectins are a family of glycan-binding proteins qualified by their affinity for β-galactosides 
and the presence of typical carbohydrate recognition domains (CRDs)
41
. Several studies have 
shown that the linker’s role, responsible for  the intramolecular interactions of CRDs, is 
associated with the ability to induce a specific biological response
42
. For these reasons, 
galectins are hopeful candidates as diagnostic markers and novel drugs targets for human 
diseases
43,44,45
.  
CTL-PEG-AuNPs were used as building blocks to observe the biomolecular interaction with 
Galectin-1 (Gal-1) as protein that plays a key role in some biological processes. In order to 
(%
)
achieve the mechanism of interaction between Gal-1 and CTL-PEG-AuNPs, Gal-1 proteins 
were incubated at different concentrations in the AuNPs solutions (scheme 2). Gal-1 interacts 
through high binding affinity with CTL as showed by SPR measurements. The protein 
interaction   with CTL-PEG-AuNPs was evaluated by UV-visible absorption (Figure 2). As a 
matter of fact, the extinction spectrum of the AuNPs is characterized by the plasmon 
resonance that is strongly dependent on the AuNPs environment, especially to any 
modification of the local dielectric constant. As a consequence, when Gal-1 interacts with 
CTL-PEG-AuNPs, it will modify the local environment, thus inducing a shift of the plasmon 
band. When Gal-1 was added to CTL-PEG-AuNPs in the range from 1 µM to 1 pM, we 
observed a dynamic variation of the plasmon position and width depending on the Gal-1 
amount. Lowering the concentration of protein from 1 µM to 1 pM, we observed that the 
plasmon band red-shifted with a decrease of its width. Therefore, we assumed that the 
grafting of Gal-1 onto CTL-PEG-AuNPs surface induced some agglomeration of the 
nanoparticles due to the interaction with Gal-1 at the gold surface. The weak red shift and the 
decrease of the plasmon band can then be explained by a lower nanoparticle aggregation and a 
dissociation of agglomerates after the addition of Gal-1 at a concentration of 1 nM (scheme 
2). It means that from 1 µM up to 1 pM, Gal-1 interacts with the CTL-PEG-AuNPs inducing 
very small changes on the plasmon band (modification of the dielectric constant around the 
AuNPs with the addition of Gal-1 proteins and maybe few dissociations). At concentrations 
higher than 1 nM, a large number of Gal-1 proteins are expected to interact with the CTL-
PEG-AuNPs forming a Gal-1 monolayer at the AuNPs surface. From 1 nM, the number of the 
Gal-1 is then large enough to prevent any interactions between the proteins on CTL-PEG-
AuNPs, thus inducing the dissociation of the nanoparticle agglomerates. Hence, at these 
concentrations we observed a blue shift of the peak due to the CTL-PEG layer from 234 nm to 
217 nm (Figure 2A’) with the consequent decrease of the plasmon band. This effect can be 
due to the formation of a shell of proteins adsorbed onto the CTL-PEG-AuNPs that 
incessantly exchange with CTL at high concentration of Gal-1 in the environment. With the 
saturation of the surface of the AuNPs, we can suppose that it could induce a better 
orientation of the Gal-1 or a change of its conformation due to chemical hindrance and also 
due to protein conformation changes. The evolution of the CTL-PEG-AuNPs plasmonic 
bands versus the Gal-1 concentration is displayed in Figure 2B. 
 
 
Scheme 2. Schematic representation of interaction mechanism of Galectin-1 onto CTL-PEG-AuNPs 
(A) and subsequent conformational change of galectin molecules under specific concentrations of 
protein (B) (Please note that drawings are not in scale and are not intended to be representative of the 
full samples composition). 
 
 
  
 
Figure 2. A) UV-Vis absorption spectra in the range 200-900 nm of CTL-PEG-AuNPs before (black 
line) and after (red line) interaction of Galectin-1 (from 1 µM to 1 pM) under straight condition (NaCl 
0.9%); A’) Enlargement of UV-Vis absorption spectra in the range 200-400 nm of CTL-PEG-AuNPs 
before and after interaction of Galectin-1. B) Evolution of the CTL-PEG-AuNPs plasmonic bands 
versus the Gal-1 concentration.  
 
The protein interaction with CTL-PEG-AuNPs was also characterized by TEM. Such 
bioconjugates have a spherical shape (Figure 3A-B) with a diameter close to 20 nm. 
Following Gal-1 interaction onto CTL-PEG-AuNPs, we observed characteristic linear chain 
likely (Figure 3B-B’) objects, due to the preferential location of CTL-PEG and Gal-1 onto the 
particle surface.  
(µM)
 Figure 3. TEM images of CTL-PEG-AuNPs before (A-A’) and after interaction of Galectin-1 (B-B’). 
Scale bars: 100 nm; 20 nm (low A-B and high B-B’ magnification). Directional arrows showing a 
metal core of around 20 nm and suggesting the presence of an organic CTL-PEG layer of few 
nanometers. 
 
The Gal-1 interaction was confirmed by DLS and Zeta potential measurements (Table S1 in 
Supporting Information). The hydrodynamic diameter of CTL-PEG-AuNPs  was slightly 
higher (about 5 nm) than the radius determined by TEM analyses. This discrepancy should 
take into account the overestimation of the hydrodynamic diameter due to the surrounding 
water molecules. Besides, the  -potential measurements show that CTL-PEG-AuNPs and 
Gal-1 CTL-PEG-AuNPs were colloidally stable at physiological pH ( -potential = -29 ± 2 
mV, for CTL-PEG-AuNPs and -25 ± 1 mV for Gal-1 CTL-PEG-AuNPs with a PDI equal to 
0..3± 2).  
5 nm 5 nm
100nm
A) A’)
B) B’)
The stability of CTL-PEG-AuNPs and Gal-1 CTL-PEG-AuNPs was verified in solution by 
visualizing the Localized Surface Plasmon (LSP) band at 530 nm. The analysis was carried 
out at pH 4 and electrolytic conditions up to 3 months. The synthesized CTL-PEG-AuNPs and 
Gal-1 CTL-PEG-AuNPs showed an almost negligible change in the LSP band position in the 
timeframe investigated (Figure S2A-B in Supporting Information). The LPS band intensity 
was almost constant in the first 15 days of incubation, thus indicating the perfect stability of 
the systems. A slight (tolerable) reduction of LPS band intensity was noticed at 1 month. If 
the incubation is prolonged up to 3 months, a marked reduction of the absorbance was 
detected for both CTL-PEG AuNPs and Gal-1 CTL-PEG-AuNPs, thus suggesting that the 
systems were almost unstable for long storage purposes.   
The successful interaction of Gal-1 onto CTL-PEG-AuNPs surface was  established by 
Raman spectroscopy at different Gal-1 concentrations (Figure 4). The detection of the 
fingerprint of CTL and PEG-COOH at the AuNPs surface was demonstrated through the 
observation of the Raman bands at 1137 cm
-1
, 1270 cm
-1
, and 1455 cm
-1
 due to the vibration 
of C-O-H, C-O-C and C-O chemical groups, respectively (Figure 4A-A’). After the Gal-1 
binding, the amide II (1587-1620 cm
- 1
) and amide III (1200-1300 cm
- 1
 regions), as well as 
modifications in protein local environments, confirmed the protein interaction (Figure 4A-
A’). When the protein concentration decreased from 500 nM to 1 pM, the fingerprint of amide 
band was masked by water peak at 1600 cm
-1
 due to the ionic environment. 
 
 
 
 
 
  
Figure 4. A) Raman spectra of the CTL-PEG-AuNPs (red line) and Gal-1 CTL-PEG-AuNPs 
(Galectin-1 concentration range 1 µM - 1 pM) compared to free CTL (black line). A’) Zoom raman 
spectra of Gal-1 CTL-PEG-AuNPs from 1 µM to 500 nM; directional arrows show the characteristic 
peaks during protein interaction. Experimental conditions: λexc = 785 nm; laser power 20 mW; 
accumulation time 180 s. 
 
By evaluating the Raman results it was possible to confirm that the chemical and steric 
conformation of Gal-1 depend on molecule concentration,that influences in turn the 
bioconjugation with CTL-PEG-AuNPs. In fact, the self-assembly of the Gal-1 on the CTL-
PEG-AuNPs will take place due to their great packing density as well as to the forces 
repulsion between the negatively charged Gal-1
30,46
. However, the self-assembly of the Gal-1 
on the CTL-PEG-AuNPs from 1 µM to 1 nM puts in evidence amide bands; in the presence of 
lower Gal-1 concentrations (from 1 µM to 1 pM) amide bands progressively disappear. This 
phenomenon is probably due to the swelling of polymers in water that interferes with protein 
steric conformation at low concentration. Similar analyses of Gal-1 interaction (UV-Vis and 
Raman) (Figure S5 in Supporting Information) were carried out in the presence of PEG-
AuNPs as control, under the same experimental conditions, confirming the selectivity of 
interaction between CTL-PEG-AuNPs and Gal-1. In fact, after incubating PEG-AuNPs and 
Gal-1 at maximal concentration (1 µM), we did not observe any signal variation. 
 
Selectivity of Galectin versus CTL-PEG-AuNPs: 
To confirm the selectivity of Gal-1 versus CTL, a preliminary test in the presence of collagen 
type I was carried out. Collagen (Col), is one of the several structural proteins in the 
extracellular matrix (ECM), over expressed in many type of cancer. For this purpose it has 
been entirely used in biomedical and biomaterial applications
47
. Col solution and Col/Gal-1 
mixture solution were incubated at room temperature with CTL-PEG-AuNPs at 1 µM for 18 
h, and the interaction was monitored by UV-Vis and Raman spectroscopy.  
Figure 5A shows a shift of the plasmon position from 530 nm before interaction (black line) 
to 539 nm after the binding (red line) with the Col/Gal-1 mixture. A weak widened peak at 
640 nm is probably due to agglomeration between gold particles after the capture of the 
protein at the particle surface due to modification of the surface charges. 
The protein interaction was confirmed by Raman spectroscopy. After the Col-Gal-1 
interaction onto CTL-PEG-AuNPs, the Raman spectrum is perfectly equivalent to Raman 
spectra related to single Gal-1 interaction onto CTL-PEG-AuNPs. Indeed the amide II (1587-
1620 cm
-1
) and amide III (1200-1300 cm
-1
 regions), confirmed that the Gal-1 protein is 
effectively captured at the AuNPs surface (Figure 5B). Moreover, the spectroscopical 
fingerprint of collagen is not observable. In order to assume the success of this analysis, we 
checked the interaction of Col free onto CTL-PEG-AuNPs as control (Figure S6A-B in 
Supporting Information), under the same experimental conditions. Figure S6 puts in 
evidence that, when Col was added to CTL-PEG-AuNPs, a negligible blue shift was observed 
in UV-Vis Spectra at 1 pM probably due to the chemical exchange between Col and PEG 
onto AuNPs surface (Figure S6A red line). However, at 1 µM, we noticed a decreased and 
widened peak, with a strong red shift at 680 nm due to the aggregation of AuNPs. The 
comparative Raman spectra at 1 pM (red line) and 1 µM (blue line) (Figure S6 B in 
Supporting Information), did not show any remarkable spectroscopical modification. This 
means that there was no capture of the Col at the AuNPs surface even at high concentration of 
Col. We thus can conclude that the CTL-PEG-AuNPs surface selectively interacts with the 
Gal-1.  
 
Figure 5. (A) Normalized UV-Vis absorption spectrum of CTL-PEG-AuNPs before (black line) and 
after (red line) incubation with a mixture of Collagen (I) and Gal-1 at 1 µM, (B) Raman spectrum of 
CTL-PEG-AuNPs (red line) after interaction with a mixture of Collagen (I) and Gal-1 at 1 µM, 
compared to free CTL-PEG-AuNPs spectrum as control (black line). Raman spectra experimental 
conditions: λexc = 785 nm; laser power 20 mW; accumulation time 180 s. 
 
 
 
CONCLUSIONS 
In this paper, we studied for the first time the bio-interaction between Galectin-1 and CTL-
PEGylated gold nanoparticles. The analysis of the UV-visible and Raman spectra, allowed us 
to highlight the formation of agglomerates due to high binding affinity between Gal-1 and 
CTL onto gold nanoparticles. We observed some dissociation for specific Gal-1 
concentrations giving evidence of the interaction of the protein with the CTL by SPR 
experiments. This paper allows the way to a better understanding of the interaction 
mechanism (chemical structure modifications, kinetic interaction) and to the sensing 
optimization since the detection sensitivity is directly related to the affinity of the bioreceptor 
to the analyte. Further investigations are further needed to assess the in vitro and in vivo 
selectivity of the present system toward different cancer models. 
 
Materials and methods 
Materials 
Tetrachloroauric acid (HAuCl4), sodium borohydride (NaBH4), dicarboxylic PolyEthylene 
Glycol (PEG)-600 (PEG), Sodium Chloride NaCl (0.9%) phosphate-buffered solution (PBS), 
collagen type I were all provided by Sigma Aldrich at maximum purity grade. Recombinant 
Human Galectin-1 (Lot# 0707271-1) was purchased from PeproTech (Rocky Hill, NJ, USA). 
Hydrochloride CTL was kindly provided by BiopoLife S.r.l. (Trieste, Italy). The chemical 
composition of CTL was determined by 
1
H-NMR spectroscopy and resulted to be: fraction of 
deacetylated units (FD) 0.36, fraction of lactose-modified units (FL) 0.56 and fraction of 
acetylated units (FA) 0.08. The physical properties were determined by viscometry: the 
intrinsic viscosity,    , of CTL was checked  at 25 °C by means of a CT 1150 Schott Geräte 
automatic measuring apparatus and a Schott capillary viscometer. A buffer solution composed 
by 20 mM AcOH/AcNa, pH 4.5, and 100 mM NaCl was used as solvent
11
. The resulting      
was 511 mL/g. The estimated viscosity average molecular weight,    of CTL was around 870 
000. 
 
 
Surface Plasmon Resonance analysis 
The interaction between CTL and Gal-1 was assessed by means of a Biacore TM 2000 
Instrument (BIAcore, Uppsala, Sweden) using a Chip sensor CM5 (GE Healthcare). CTL was 
immobilized on the chip following manufacturer’s instructions. Briefly, CTL was dissolved in 
AcOH/AcNa buffer, pH 4.5, at a concentration of 0.05 g/L. Subsequently, CTL was injected 
(30 μL/min) on the chip surface until a SPR signal of approximately 800 RU was observed. 
Gal-1 solubilization and binding measurements were performed in PBS buffer, pH 7, 
supplemented with dithiothreitol (DTT-2 mM) and P20 detergent (0.005%). Gal-1 solutions in 
a range of concentrations 0.12 - 8 μM were injected over the sensor chip surface at 30 
μL/min. Flow channel Fc1 has been used as negative control. The chip was regenerated by 
injection of lactose 10 mM. Data analysis has been performed by the BIA evaluation 3.2 
Software (Biacore). A Langmuir 1:1 model was used for the calculation of rate constants (for 
details see Supplementary Information).  
 
Preparation of CTL and Galectin protein solutions 
CTL was solubilized at a concentration equal to 1 mg/mL in Milli-Q water (final pH around 
3). Galectin powder was solubilized in water and then diluted in order to obtain solutions with 
concentrations comprised within the range 1 μM – 1 pM. Molar concentrations of Galectin-1 
were determined taking into account that molecular weight of Galectin-1 is equal to 14716 
Da. 
 
Preparation of Collagen and Galectin protein solutions (selectivity test) 
Galectin and Collagen were solubilized in water and mixed together to obtain a solution at 
concentration of 1 μM. 
 
Synthesis of CTL PEG-AuNPs (CTL PEG-AuNPs) 
Colloids of CTL- PEG-coated AuNPs (CTL-PEG-AuNPs) were synthesize by a well-
established chemical reduction process described in Scheme 1. Briefly, 250 µL of PEG 
solution (0.5 mM) was added to 20 mL of tetrachloroauric acid solution (2.4 x 10
-4
 M) under 
stirring at room temperature. Then 5 mL of CTL solution (1 mg/mL) and 2 mL of aqueous 
0.01 M NaBH4 were added drop by drop with precaution until solution turned into a violet 
color. The concentration was estimated by standard mathematical calculations in colloidal 
solution. 
 
Determination of CTL-PEG-AuNPs concentration 
AuNPs concentration was determined by exploiting standard mathematical calculations in 
colloidal solution. Lambert-Beer law (       ) was used to determine colloids 
concentration. In this equation A is the maximum absorbance (corresponding to the Surface 
Plasmon Resonance Band at around 530-540 nm) of the UV-visible spectrum,   is the molar 
extinction coefficient (equal to 3.07 × 10
10
 M
-1 
cm
-1
), C is the molar concentration of colloids 
and l is the optical length of cuvette (1 cm). The resulting C was multiplied for the dilution 
factor to obtain the concentration of colloids. 
 
Bioconjugation of CTL-PEG-AuNPs with Gal-1 
The interaction of Gal-1 protein with CTL-PEG-AuNPs surface was obtained exploiting the 
procedures depicted in Scheme 2. Briefly, 5 mL of CTL-PEG-AuNPs (42nM) were added into 
separate tubes containing 50 µL of Gal-1 (from 10 µM to 1 pM; PBS pH 7; NaCl 0.15 M). 
After 18 h of incubation, the CTL-PEG-AuNPs/Gal-1 suspension was centrifuged twice at 
5000 rpm for 10 min to eliminate the excess of Gal-1 and then the pellets were redispersed in 
1 mL of MilliQ water as described previously 
8
.  
 
Physical-chemical characterization  
All the measurements were accomplished in triplicate to confirm the reproducibility of the 
synthetic and analytical procedures. 
 
UV/Vis measurements 
Absorption spectra were recorded using a double-beam Varian Cary 500 UV-Vis 
spectrophotometer (Agilent, France). UV-Vis spectra of the AuNPs were achieved in water at 
concentration of 42 nM in the 200-900 nm spectral range.  
 
Transmission Electron Microscopy (TEM) 
Transmission Electron Microscopy (TEM) images were recorded with a JEOL JEM 1011 
microscope operating (JEOL, USA) at an accelerating voltage of 100 kV. TEM specimens 
were prepared after separating the surfactant from the metal particles by centrifugation under 
a protocol described  previously
8
.  
Raman Spectroscopy 
The Raman experiments have been performed on an Xplora spectrometer (Horiba Scientifics-
France) under a protocol described previously 
8
.  
 
 
 
Dynamic light scattering (DLS) and Zeta potential measurements 
The size and zeta potential measurements were performed using a Zetasizer Nano ZS 
(Malvern Instruments, Malvern, UK) equipped with a He-Ne laser (633 nm, fixed scattering 
angle of 173°) at room temperature as described previously
35
. 
 
Stability of CTL-PEG-AuNPs and Gal-1 CTL-PEGAuNPs as a function of pH. 
The stability of nanoparticles was detected by UV-Vis. All nanoparticles were dissolved in 
PBS solution 10 mM at pH 4 and stored for 3 months (Figure S2 in Supporting 
Information). 
 
 
ASSOCIATED CONTENT 
Supporting Information. Supplementary figures, schemes and tables are provided. This 
material is available free of charge via the Internet at http://pubs.acs.org. 
Corresponding Author: jolanda.spadavecchia@univ-paris13.fr* 
 
Author Contributions 
The manuscript was written through contributions of all authors. All authors have given 
approval to the final version of the manuscript. ‡These authors (Qiqian Liu, Pasquale Sacco) 
contributed equally. 
 
ACKNOWLEDGMENT 
This work has been partly performed on the CNanoMat platform of the University Paris 13. 
This study was supported by the University of Trieste (FRADONATI2016-17) and by the 
INTERREG V-A ITALIA-SLOVENIA 2014-2020 BANDO 1/2016 ASSE 1 - project BioApp 
1472551605. 
References: 
1. Marcon, P.; Marsich, E.; Vetere, A.; Mozetic, P.; Campa, C.; Donati, I.; Vittur, F.; Gamini, A.; 
Paoletti, S., The role of Galectin-1 in the interaction between chondrocytes and a lactose-modified 
chitosan. Biomaterials 2005, 26 (24), 4975-84. 
2. Sapsford, K. E.; Algar, W. R.; Berti, L.; Gemmill, K. B.; Casey, B. J.; Oh, E.; Stewart, M. H.; 
Medintz, I. L., Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that 
Facilitate Nanotechnology. Chemical Reviews 2013, 113 (3), 1904-2074. 
3. Moore, T. L.; Rodriguez-Lorenzo, L.; Hirsch, V.; Balog, S.; Urban, D.; Jud, C.; Rothen-
Rutishauser, B.; Lattuada, M.; Petri-Fink, A., Nanoparticle colloidal stability in cell culture media and 
impact on cellular interactions. Chemical Society Reviews 2015, 44 (17), 6287-6305. 
4. Jans, H.; Liu, X.; Austin, L.; Maes, G.; Huo, Q., Dynamic Light Scattering as a Powerful Tool for 
Gold Nanoparticle Bioconjugation and Biomolecular Binding Studies. Analytical Chemistry 2009, 81 
(22), 9425-9432. 
5. Politi, J.; De Stefano, L.; Longobardi, S.; Giardina, P.; Rea, I.; Methivier, C.; Pradier, C. M.; 
Casale, S.; Spadavecchia, J., The amphiphilic hydrophobin Vmh2 plays a key role in one step synthesis 
of hybrid protein-gold nanoparticles. Colloids and surfaces. B, Biointerfaces 2015, 136, 214-21. 
6. Spadavecchia, J.; Apchain, E.; Alberic, M.; Fontan, E.; Reiche, I., One-step synthesis of 
collagen hybrid gold nanoparticles and formation on Egyptian-like gold-plated archaeological ivory. 
Angew Chem Int Ed Engl 2014, 53 (32), 8363-6. 
7. Spadavecchia, J.; Perumal, R.; Barras, A.; Lyskawa, J.; Woisel, P.; Laure, W.; Pradier, C. M.; 
Boukherroub, R.; Szunerits, S., Amplified plasmonic detection of DNA hybridization using 
doxorubicin-capped gold particles. Analyst 2014, 139 (1), 157-64. 
8. Spadavecchia, J.; Movia, D.; Moore, C.; Maguire, C. M.; Moustaoui, H.; Casale, S.; Volkov, Y.; 
Prina-Mello, A., Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic 
cancer: from synthesis to proof-of-concept in vitro studies. Int J Nanomedicine 2016, 11, 791-822. 
9. Tammam, S. N.; Khalil, M. A. F.; Abdul Gawad, E.; Althani, A.; Zaghloul, H.; Azzazy, H. M. E., 
Chitosan gold nanoparticles for detection of amplified nucleic acids isolated from sputum. 
Carbohydrate polymers 2017, 164, 57-63. 
10. Donati, I.; Travan, A.; Pelillo, C.; Scarpa, T.; Coslovi, A.; Bonifacio, A.; Sergo, V.; Paoletti, S., 
Polyol Synthesis of Silver Nanoparticles: Mechanism of Reduction by Alditol Bearing Polysaccharides. 
Biomacromolecules 2009, 10 (2), 210-213. 
11. Furlani, F.; Sacco, P.; Marsich, E.; Donati, I.; Paoletti, S., Highly monodisperse colloidal 
coacervates based on a bioactive lactose-modified chitosan: From synthesis to characterization. 
Carbohydrate polymers 2017, 174, 360-368. 
12. Manivasagan, P.; Bharathiraja, S.; Bui, N. Q.; Lim, I. G.; Oh, J., Paclitaxel-loaded chitosan 
oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic 
imaging of cancer cells. International journal of pharmaceutics 2016, 511 (1), 367-379. 
13. Collado-Gonzalez, M.; Montalban, M. G.; Pena-Garcia, J.; Perez-Sanchez, H.; Villora, G.; Diaz 
Banos, F. G., Chitosan as stabilizing agent for negatively charged nanoparticles. Carbohydrate 
polymers 2017, 161, 63-70. 
14. Donati, I.; Stredanska, S.; Silvestrini, G.; Vetere, A.; Marcon, P.; Marsich, E.; Mozetic, P.; 
Gamini, A.; Paoletti, S.; Vittur, F., The aggregation of pig articular chondrocyte and synthesis of 
extracellular matrix by a lactose-modified chitosan. Biomaterials 2005, 26 (9), 987-98. 
15. (a) Marsich, E.; Travan, A.; Feresini, M.; Lapasin, R.; Paoletti, S.; Donati, I., 
Polysaccharide‐Based Polyanion–Polycation–Polyanion Ternary Systems in the Concentrated Regime 
and Hydrogel Form. Macromolecular Chemistry and Physics 2013, 214 (12), 1309-1320; (b) Sacco, P.; 
Furlani, F.; Cok, M.; Travan, A.; Borgogna, M.; Marsich, E.; Paoletti, S.; Donati, I., Boric Acid Induced 
Transient Cross-Links in Lactose-Modified Chitosan (Chitlac). Biomacromolecules 2017, 18 (12), 4206-
4213; (c) Cok, M.; Sacco, P.; Porrelli, D.; Travan, A.; Borgogna, M.; Marsich, E.; Paoletti, S.; Donati, I., 
Mimicking mechanical response of natural tissues. Strain hardening induced by transient reticulation 
in lactose-modified chitosan (chitlac). Int J Biol Macromol 2018, 106, 656-660. 
16. Travan, A.; Marsich, E.; Donati, I.; Foulc, M.-P.; Moritz, N.; Aro, H. T.; Paoletti, S., 
Polysaccharide-Coated Thermosets for Orthopedic Applications: From Material Characterization to In 
Vivo Tests. Biomacromolecules 2012, 13 (5), 1564-1572. 
17. Lei, M.; Liu, S.-q.; Liu, Y.-l., Resveratrol protects bone marrow mesenchymal stem cell derived 
chondrocytes cultured on chitosan-gelatin scaffolds from the inhibitory effect of interleukin-1β. Acta 
Pharmacologica Sinica 2008, 29, 1350. 
18. Marsich, E.; Borgogna, M.; Donati, I.; Mozetic, P.; Strand, B. L.; Salvador, S. G.; Vittur, F.; 
Paoletti, S., Alginate/lactose-modified chitosan hydrogels: a bioactive biomaterial for chondrocyte 
encapsulation. J Biomed Mater Res A 2008, 84 (2), 364-76. 
19. Mendoza, G.; Regiel-Futyra, A.; Andreu, V.; Sebastián, V.; Kyzioł, A.; Stochel, G.; Arruebo, M., 
Bactericidal Effect of Gold–Chitosan Nanocomposites in Coculture Models of Pathogenic Bacteria and 
Human Macrophages. ACS Applied Materials & Interfaces 2017, 9 (21), 17693-17701. 
20. Marsich, E.; Travan, A.; Donati, I.; Di Luca, A.; Benincasa, M.; Crosera, M.; Paoletti, S., 
Biological response of hydrogels embedding gold nanoparticles. Colloids and surfaces. B, 
Biointerfaces 2011, 83 (2), 331-9. 
21. Barrow, H.; Rhodes, J. M.; Yu, L. G., The role of galectins in colorectal cancer progression. Int J 
Cancer 2011, 129 (1), 1-8. 
22. Dalotto-Moreno, T.; Croci, D. O.; Cerliani, J. P.; Martinez-Allo, V. C.; Dergan-Dylon, S.; 
Méndez-Huergo, S. P.; Stupirski, J. C.; Mazal, D.; Osinaga, E.; Toscano, M. A.; Sundblad, V.; 
Rabinovich, G. A.; Salatino, M., Targeting Galectin-1 Overcomes Breast Cancer-Associated 
Immunosuppression and Prevents Metastatic Disease. Cancer Research 2013, 73 (3), 1107-1117. 
23. Szöke, T.; Kayser, K.; Baumhäkel, J. D.; Trojan, I.; Furak, J.; Tiszlavicz, L.; Horvath, A.; Szluha, 
K.; Gabius, H. J.; Andre, S., Prognostic Significance of Endogenous Adhesion/Growth-Regulatory 
Lectins in Lung Cancer. Oncology 2005, 69 (2), 167-174. 
24. Saussez, S.; Camby, I.; Toubeau, G.; Kiss, R., Galectins as modulators of tumor progression in 
head and neck squamous cell carcinomas. Head & Neck 2007, 29 (9), 874-884. 
25. Chow, S. N.; Chen, R. J.; Chen, C. H.; Chang, T. C.; Chen, L. C.; Lee, W. J.; Shen, J.; Chow, L. P., 
Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology. Eur J 
Gynaecol Oncol 2010, 31 (1), 55-62. 
26. Laderach, D. J.; Gentilini, L. D.; Giribaldi, L.; Delgado, V. C.; Nugnes, L.; Croci, D. O.; Al Nakouzi, 
N.; Sacca, P.; Casas, G.; Mazza, O.; Shipp, M. A.; Vazquez, E.; Chauchereau, A.; Kutok, J. L.; Rodig, S. J.; 
Elola, M. T.; Compagno, D.; Rabinovich, G. A., A unique galectin signature in human prostate cancer 
progression suggests galectin-1 as a key target for treatment of advanced disease. Cancer Res 2013, 
73 (1), 86-96. 
27. Gandhi, M. K.; Moll, G.; Smith, C.; Dua, U.; Lambley, E.; Ramuz, O.; Gill, D.; Marlton, P.; 
Seymour, J. F.; Khanna, R., Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell 
immunity in classic Hodgkin lymphoma. Blood 2007, 110 (4), 1326-1329. 
28. Thijssen, V. L.; Heusschen, R.; Caers, J.; Griffioen, A. W., Galectin expression in cancer 
diagnosis and prognosis: A systematic review. Biochim Biophys Acta 2015, 2, 235-47. 
29. Astorgues-Xerri, L.; Riveiro, M. E.; Tijeras-Raballand, A.; Serova, M.; Neuzillet, C.; Albert, S.; 
Raymond, E.; Faivre, S., Unraveling galectin-1 as a novel therapeutic target for cancer. Cancer Treat 
Rev 2014, 40 (2), 307-19. 
30. Pieters, R. J., Inhibition and Detection of Galectins. ChemBioChem 2006, 7 (5), 721-728. 
31. Bourne, Y.; Bolgiano, B.; Liao, D.-I.; Strecker, G.; Cantau, P.; Herzberg, O.; Feizi, T.; Cambillau, 
C., Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides. Nature 
Structural Biology 1994, 1, 863. 
32. Rajeeva, B. B.; Hernandez, D. S.; Wang, M.; Perillo, E.; Lin, L.; Scarabelli, L.; Pingali, B.; 
Liz‐Marzán, L. M.; Dunn, A. K.; Shear, J. B.; Zheng, Y., Regioselective Localization and Tracking of 
Biomolecules on Single Gold Nanoparticles. Advanced Science 2015, 2 (11), 1500232. 
33. Richman, S. A.; Kranz, D. M.; Stone, J. D., Biosensor detection systems: engineering stable, 
high-affinity bioreceptors by yeast surface display. Methods in molecular biology (Clifton, N.J.) 2009, 
504, 323-50. 
34. Vo-Dinh, T., Nanosensing at the single cell level(). Spectrochimica acta. Part B: Atomic 
spectroscopy 2008, 63 (2), 95-103. 
35. Moustaoui, H.; Movia, D.; Dupont, N.; Bouchemal, N.; Casale, S.; Djaker, N.; Savarin, P.; Prina-
Mello, A.; de la Chapelle, M. L.; Spadavecchia, J., Tunable Design of Gold(III)-Doxorubicin Complex-
PEGylated Nanocarrier. The Golden Doxorubicin for Oncological Applications. ACS Appl Mater 
Interfaces 2016, 8 (31), 19946-57. 
36. Miller, M. C.; Nesmelova, I. V.; Platt, D.; Klyosov, A.; Mayo, K. H., The carbohydrate-binding 
domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: 
implications for galectin-glycan interactions at the cell surface. The Biochemical journal 2009, 421 (2), 
211-21. 
37. Collins, B. E.; Paulson, J. C., Cell surface biology mediated by low affinity multivalent protein-
glycan interactions. Current opinion in chemical biology 2004, 8 (6), 617-25. 
38. Bumba, L.; Laaf, D.; Spiwok, V.; Elling, L.; Kren, V.; Bojarova, P., Poly-N-Acetyllactosamine 
Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling. 
International journal of molecular sciences 2018, 19 (2). 
39. Stowell, S. R.; Arthur, C. M.; Mehta, P.; Slanina, K. A.; Blixt, O.; Leffler, H.; Smith, D. F.; 
Cummings, R. D., Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood 
group antigens. The Journal of biological chemistry 2008, 283 (15), 10109-23. 
40. Marguerit, G.; Moustaoui, H.; Haddada, M. B.; Djaker, N.; Chapelle, M. L.; Spadavecchia, J., 
Taxanes Hybrid Nanovectors: From Design to Physico‐Chemical Evaluation of Docetaxel and 
Paclitaxel Gold (III)‐PEGylated Complex Nanocarriers. Particle & Particle Systems Characterization 
2018, 35 (2), 1700299. 
41. Johannes, L.; Wunder, C.; Shafaq-Zadah, M., Glycolipids and Lectins in Endocytic Uptake 
Processes. Journal of molecular biology 2016. 
42. Cousin, J. M.; Cloninger, M. J., The Role of Galectin-1 in Cancer Progression, and Synthetic 
Multivalent Systems for the Study of Galectin-1. International Journal of Molecular Sciences 2016, 17 
(9), 1566. 
43. Chuang, C.-H.; Du, Y.-C.; Wu, T.-F.; Chen, C.-H.; Lee, D.-H.; Chen, S.-M.; Huang, T.-C.; Wu, H.-
P.; Shaikh, M. O., Immunosensor for the ultrasensitive and quantitative detection of bladder cancer 
in point of care testing. Biosens Bioelectron 2016, 84, 126-132. 
44. Ebrahim, A. H.; Alalawi, Z.; Mirandola, L.; Rakhshanda, R.; Dahlbeck, S.; Nguyen, D.; Jenkins, 
M.; Grizzi, F.; Cobos, E.; Figueroa, J. A.; Chiriva-Internati, M., Galectins in cancer: carcinogenesis, 
diagnosis and therapy. Annals of Translational Medicine 2014, 2 (9), 88. 
45. Besford, Q. A.; Wojnilowicz, M.; Suma, T.; Bertleff-Zieschang, N.; Caruso, F.; Cavalieri, F., 
Lactosylated Glycogen Nanoparticles for Targeting Prostate Cancer Cells. ACS applied materials & 
interfaces 2017, 9 (20), 16869-16879. 
46. Belitsky, J. M.; Nelson, A.; Hernandez, J. D.; Baum, L. G.; Stoddart, J. F., Multivalent 
interactions between lectins and supramolecular complexes: Galectin-1 and self-assembled 
pseudopolyrotaxanes. Chem Biol 2007, 14 (10), 1140-51. 
47. Xu, B.; Chow, M.-J.; Zhang, Y., Experimental and Modeling Study of Collagen Scaffolds with 
the Effects of Crosslinking and Fiber Alignment. International Journal of Biomaterials 2011, 2011, 
172389. 
 
 
